Stocksigma LogoStocksigma Logo

Genpharmasec Schedules Board Meeting to Approve Q2 Results

Genpharmasec Limited has scheduled a Board of Directors meeting on 3rd Nov'26 to consider and approve the un-audited standalone and consolidated financial

Genpharmasec Schedules Board Meeting to Approve Q2 Results

Genpharmasec Ltd 路 Intimation 路 03 Nov 2026, 5:30 am

Genpharmasec Schedules Board Meeting to Approve Q2 Results Genpharmasec Limited has scheduled a Board of Directors meeting on 3rd Nov'26 to consider and approve the un-audited standalone and consolidated financial results, along with the Limited Review Report, for the quarter and half-year ended 30th Sep'26. In compliance with SEBI insider trading regulations, the trading window for dealing in company securities has been closed from 1st Oct'26 and will reopen 48 hours following the formal declaration of the financial results.

Original exchange filing (PDF)

More announcements from Genpharmasec Ltd

All Genpharmasec Ltd announcements